| 000 | 01091 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516114521.0 | ||
| 264 | 0 | _c20130408 | |
| 008 | 201304s 0 0 ger d | ||
| 022 | _a1435-1250 | ||
| 024 | 7 |
_a10.1007/s00393-012-0971-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWendler, J | |
| 245 | 0 | 0 |
_a[Is treat to target compatible with health insurance and health insurance funds?]. _h[electronic resource] |
| 260 |
_bZeitschrift fur Rheumatologie _cOct 2012 |
||
| 300 |
_a643-8 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xeconomics |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xeconomics |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 |
_aHealth Care Costs _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsurance, Health, Reimbursement _xeconomics |
| 650 | 0 | 4 |
_aNational Health Programs _xeconomics |
| 700 | 1 | _aEdelmann, E | |
| 773 | 0 |
_tZeitschrift fur Rheumatologie _gvol. 71 _gno. 8 _gp. 643-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00393-012-0971-2 _zAvailable from publisher's website |
| 999 |
_c22172600 _d22172600 |
||